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ABSTRACT This report describes what to our knowledge is the ﬁrst kinetic folding studies of erythropoietin, a glycosylated
four-helical bundle cytokine responsible for the regulation of red blood cell production. Kinetic responses for folding and unfolding
reactions initiated by manual mixing were monitored by far-ultraviolet circular dichroism and ﬂuorescence spectroscopy, and
folding reactions initiated by stopped-ﬂow mixing were monitored by ﬂuorescence. The urea concentration dependence of the
observed kinetics were best described by a three-statemodel with a transiently populated intermediate species that is on-pathway
and obligatory. This folding scheme was further supported by the excellent agreement between the free energy of unfolding and
m-value calculated from the microscopic rate constants derived from this model and these parameters determined from separate
equilibrium unfolding experiments. Compared to the kinetics of other members of the four-helical bundle cytokine family, erythro-
poietin folding and unfolding reactions were slower and less susceptible to aggregation.We tentatively attribute these slower rates
and protection from association events to the large amount of carbohydrate attached to erythropoietin at four sites.INTRODUCTION
Erythropoietin (EPO) is a 30 kD hormone produced
primarily in the kidneys and is responsible for regulating
red blood cell production by stimulating late erythroid
precursor cells (1). Recombinant EPO is produced by Am-
gen under the trade name Epogen and has reached prominent
therapeutic importance for treating anemia resulting from
numerous conditions including renal failure and the use of
chemotherapy (2). Human EPO contains 165 amino acids
and ~40% of its mass consists of carbohydrate with glycosyl-
ation occurring at three N-linked and one O-linked position
(3). The NMR solution structure of a nonglycosylated
mutant has been determined and revealed that EPO shares
a high degree of structural similarity with other hematopoi-
etic cytokines despite a lack of sequence homology (4). It
is a monomeric left-handed four-helical bundle protein
consisting of four long a-helices arranged in an up-up and
down-down topology (Fig. 1). Cysteines 7 and 161 form a
disulfide bond that connect the first and last antiparallel
helices together and a second disulfide bond between
cysteine 29 and 33 bridge the C-terminal portion of the
end of the first helix with the first part of the long crossover
loop leading to the second helix (4).
Since the cloning of the gene coding for human EPO some
23 years ago (5), numerous biophysical and structural char-
acterizations of recombinant EPO have been made including
determination of its equilibrium stability by thermal and
solvent denaturation (3,6,7). To the best of our knowledge,
no kinetic studies have yet been undertaken to elucidate
the folding mechanism of EPO, or how the protein navigates
the folding landscape to reach the final native state structure
from an ensemble of unfolded states.
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0006-3495/09/05/4221/10 $2.00EPO is an attractive protein-folding model due to its inter-
mediate size and high degree of folding reversibility. A
wealth of information has already been learned studying
the folding mechanisms of other single-domain proteins,
some of which fold by strictly two-state mechanisms and
others through transiently populated intermediates (8,9).
Such information has led to the general understanding that
proteins sharing similar native state topology, but not neces-
sarily sequence homology, often fold with similar rates
through similar mechanisms (10). Folding data have already
been collected for some of the other members of the four-
helical bundle cytokine family such as the bovine and human
growth hormones (bGH and hGH) and more recently granu-
locyte stimulating factor (G-CSF) (11–13). The Escherichia
coli-expressed growth hormones and G-CSF are not glyco-
sylated and a comparison of their folding mechanism with
the Chinese hamster ovary (CHO) cell derived glycosylated
EPO may help explain what effect carbohydrate has on
protein folding mechanisms and rates, an area of research
in which little data have been collected (14,15).
MATERIALS AND METHODS
Materials
Ultra pure urea was purchased fromMP Biomedicals (Solon, OH). Urea was
prepared fresh for each experiment and concentrations were determined by
refractive index (16). All other chemicals were of reagent grade and
purchased from Sigma Aldrich (St. Louis, MO). Recombinant EPO was
expressed in CHO cells and purified as a drug product (5,17). Protein
concentrations were determined by absorbance at 280 nm using an extinc-
tion coefficient of 22,710 M1cm1.
Methods
Equilibrium denaturation
The urea-induced equilibrium unfolding of the disulfide intact EPO was
achieved by equilibrating individual samples of EPO overnight in urea
doi: 10.1016/j.bpj.2009.02.049
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140 mM NaCl, 20 mM sodium phosphate pH 6.9. Samples were analyzed
the next day by far-ultaviolet (UV) circular dichroism (CD) and intrinsic
tryptophan fluorescence (FL) spectroscopy at 25C. Far-UV CD data were
collected at 222 nm on a Jasco J-815 CD spectrophotometer using
a pathlength of 0.2 cm. FL data were collected on both a T-format Quanta
6 PTI and Varian Carrey Eclipse spectrofluorometer using an excitation
wavelength of 295 nm and monitoring emission from 305 to 400 nm.
Two separate unfolding experiments and one refolding experiment were
analyzed by CD and FL spectroscopy. The equilibrium unfolding transitions
monitored by CD and at multiple FL emission wavelengths were globally fit
to a two-state model using the data analysis program Savuka 6.2 described
elsewhere (18,19). This model uses the linear extrapolation method between
the free energy of unfolding and denaturant concentration (16) according to
Eq. 1:
DG ¼ DGðH2OÞ  m½Urea: (1)
Here DG(H2O) represents the free energy of unfolding in the absence of
denaturant, and m represents the dependence of the free energy of unfolding
on the denaturant concentration. For comparison of the data collected by the
different optical probes, data were normalized to the fraction unfolded
(Fapp):
Fapp ¼ ðYF  YiÞðYF  YUÞ: (2)
Here Yi is the observed signal at a given urea concentration, and YF and
YU are the extrapolated values of the folded and unfolded signal at the
same urea concentration.
FIGURE 1 Ribbon diagram of EPO with helices lettered A–D from the
N-terminus. Disulfide bonds are shown in yellow, and tryptophan residues
are shown in dark blue. Trp-88 is located on the short loop connecting the
antiparallel second and third helices (BC loop) and has been reported to
be largely quenched by the disulfide bond bridging cysteines 29 and 33
within the N-terminal portion of the first crossover loop (27). The figure is
derived from the structure of a nonglycosylated EPO mutant (1BUY.pdb)
described elsewhere (4) and rendered using DSviewerPro 6.0.
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Kinetic data were collected at 25C in the final buffer conditions of 10 mM
EPO, 140 mM NaCl, 20 mM sodium phosphate, pH 6.9 after rapid dilution
to various urea concentrations. Manually mixed folding and unfolding
kinetic responses of the disulfide intact EPOwere monitored at 222 nm using
a Jasco J-815 CD spectrophotometer and at 360 and 325 nm by FL after
excitation at 295 nm using and a Quanta 6 PTI and Varian Carey eclipse
spectrofluorometers. Stopped-flow FL (SF-FL) data were collected on
a Bio-logic MOS 450 spectrophotometer interfaced to a stopped-flow
SFM 400 tower and equipped with a high-density mixer. SF-FL data were
collected with an excitation wavelength of 295 nm and kinetic responses
were detected using a 320 nm cutoff filter. Dead times for SF-FL of ~5.5 ms
were calculated measuring the quenching of N-acetyltryptophanamide with
increasing concentrations of N-bromosuccinimide as described elsewhere
(20). The signal/noise ratios for SF-FL experiments were enhanced by aver-
aging 10 to 15 shots. CD and FL kinetic traces were fit locally to a single or
the sum of multiple exponential equations of the form shown in Eq. 3 with
Kaleidagraph 3.5 (Synergy Software):
YðtÞ ¼ YN þ
XN
i¼ 1
DYiexpð  t=tiÞ: (3)
Here YN is the final signal after equilibrium has been reached, DYi is the
change in signal associated with a particular kinetic phase, and ti is the relax-
ation time. The data fitting program Savuka 6.2 (18,19) was used to globally
fit the urea concentration dependence of unfolding and folding rate constants
of multiple FL and CD kinetic traces within the linear regions of the chevron
plot (see Fig. 4) to Eq. 4:
ki ¼ kH2Oexp

mz½Ureai
RT

: (4)
Here, kH2O is the rate constant in the absence of urea, and mz is proportional
to the change in solvent accessible surface area between the initial and tran-
sition state species. These parameters were used as the initial microscopic
rate constants for fitting the urea concentration dependence of the observed
rates to the three three-state folding models.
Burst-phase folding analysis
The dead time of the SF-FL instrument was subtracted from the FL kinetic
refolding traces and the signal at the time of mixing calculated using the fits
of these adjusted traces. The signal of the kinetic trace after equilibrium had
been reached was then normalized to an equilibrium unfolding curve gener-
ated using the same 320 nm cutoff filter used for the SF-FL experiments. The
time zero signal was normalized by this same amount and compared with the
extrapolated equilibrium unfolding signal at the final urea concentrations the
protein was folded to.
Data analysis
The equation describing the on-pathway mechanism (21) is given below:
f ðlÞ ¼ l2  lðkUI þ kIU þ kIN þ kNIÞ
þ ðkUIkIN þ kUIkNI þ kIUkNIÞ ¼ 0:
(5)
The observed rate constants are represented as l1 and l2 and are the roots of
f(l)¼ 0. The analytical solutions to the off-pathway and parallel-path mech-
anisms can be found in Bachmann and Kiefhaber (21). Fitting was initially
performed by fixing the microscopic rate constants and mz-values to the
results derived from the global fits of the linear regions of the chevron
plot, Eq. 4, and optimizing the microscopic rate constant and associated
mz-value for the unfolding of the intermediate species. This approach
resulted in agreement between the predicted and observed rate constants
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models, fitting was performed following the methods described by Capaldi
et al. (22), where each of the individual microscopic rate constants and
mz-values were varied manually until a satisfactory match between the
observed and predicted data were found. Kinetic traces were simulated by
calculating the amplitudes for each kinetic phase using the equations given
in Bachmann and Kiefhaber (21), and the parameters that resulted in the best
fits to the observed rates of the chevron plot for each of the three three-state
models. The free energy of each kinetic species (see Fig. 7) were calculated
using Eq. 6:
DG ¼ RTlnKeq; (6)
where the equilibrium constant was expressed as a ratio of the microscopic
rate constants given in Table 1. The unfolded state was arbitrarily set to zero,
and the height of the energy barriers between the unfolded/intermediate and
intermediate/native species were estimated using transition state theory
based on the Erying equation, Eq. 7:
k ¼ kae
DGz
RT

: (7)
The preexponential factor was set to 108 s1 as described by Krieger et al.
(23). The free energy diagram reaction coordinate represents the relative
compactness of each kinetic species and transition state or b-value. The
b-values were defined as given in Eq. 8:
bTS1 ¼ mUI=meq; bI ¼ ðmUI  mIUÞ=meq; bTS2
¼ ðmUI  mIU þ mINÞ=meq: (8)
The kinetic mz-values were taken from Table 1, and meq was determined
from the equilibrium unfolding study.
RESULTS
Equilibrium denaturation
Previously published data have shown that thermal and
chemical induced equilibrium denaturation of EPO were
reversible processes that were best fit to a two-state model
and yielded a free energy of unfolding of 6–7 kcal mol1
(3,7). We repeated these measurements using the same
solvent conditions and temperature used for the kinetic
folding studies. This was essential because moderately small
differences in salt concentration were noticed to influence
the equilibrium stability of EPO. Urea induced equilibriumunfolding was monitored by far-UV CD at 222 nm and tryp-
tophan FL from residues 51, 64, and 88. Two CD and one FL
unfolding data sets and one FL refolding data set were
collected and globally fit to a two-state model yielding
a free energy of unfolding value of 7.2  0.1 kcal mol1
and an m-value of 1.69  0.03 kcal mol1 M1. Represen-
tative equilibrium unfolding curves monitored by CD and
FL are shown with their local fits in Fig. 2 A, and the unfold-
ing data normalized to the fraction unfolded are shown with
their global fit in Fig. 2 B.
Folding of EPO
Folding reactions were initiated by rapid dilution of an
unfolded stock of EPO equilibrated overnight in 6 M urea
to various final urea concentrations by manual and
stopped-flow mixing methods. Folding was a slow process
and required between 1 and 10 min before reaching equilib-
rium when refolding to final urea concentrations ranging
from 1 to 4.5 M urea, respectively. For this reason, manual
mixing (monitored by far-UV CD and FL) was utilized
when refolding between final urea concentrations of 1 to
4.5 M, and stopped-flow mixing (monitored by FL) was
utilized when refolding between 0.6 and ~2.5 M urea.
Folding reactions monitored by SF-FL were best fit to
a sum of three exponential equations, Eq. 3, when refolding
to low urea concentrations (Fig. 3 A). The fast phase showed
an increase in FL intensity and was essentially complete
within 300 ms (Fig. 3 A, inset). This phase only accounted
for ~8% of the total change in FL signal or amplitude upon re-
folding to the lowest urea concentrations and disappeared
when folding to final urea concentrations above 1.5 M
(Fig. 3 B). The intermediate and slow kinetic phases both
showed a decrease in FL intensity as the protein folded,
with the intermediate folding phase carrying ~70% of the
FL amplitude when folding to the lowest urea concentrations.
The amount of protein folding through the slow phase
increased as EPO was folded to higher final urea concentra-
tions. By 1.8 M urea 80% of the total folding signal was
contributed by the slow folding phase, and by 2.0 M urea
the refolding of EPO monitored by SF-FL was best fit toTABLE 1 Kinetic and equilibrium parameters of EPO
Rate constant (s1) mz-value (kcal mol1 M1) DG (H2O) (kcal mol
1) m-value (kcal mol1 M1)
(U to I) 0.25 (0.01) 0.29 (0.02)
(I to U)* 0.0008 (0.0001) 0.82 (0.06)
(I to N) 0.063 (0.003) 0.08 (0.02)
(N to I) 1.07E4 (2.0E6) 0.458 (0.002)
UNy 7.2 (0.2) 1.65 (0.07)
UNz 7.2 (0.1) 1.69 (0.03)
Rate constants and mz-values (except for I to U) for on-pathway folding scheme were derived from the global fits within the linear regions of the chevron plot
to Eq. 4.
*Rate constant and associated mz-value for I to U were derived from the fit of the chevron plot to an on-pathway model, Eq. 5.
yEquilibrium unfolding parameters calculated from the microscopic rate constants.
zEquilibrium unfolding parameters determined from equilibrium unfolding experiments. The values in parentheses represent the standard deviation of the fits
of the observed rate constants and equilibrium unfolding parameters. Conditions: 140 mM NaCl, 20 mM NaPi (pH 6.9), 25C.Biophysical Journal 96(10) 4221–4230
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tration dependence of the folding reaction monitored by
SF-FL was examined by refolding to final EPO concentra-
tions of 1, 2, 5, and 10 mM. The fast kinetic phase disappeared
when refolding to EPO concentrations below 2mM.The inter-
mediate and slow folding phases, however, did not change in
FIGURE 2 (A) Representative equilibrium unfolding of EPO monitored
by far-UV CD at 222 nm (open circles) and intrinsic tryptophan FL at
325 nm (solid triangles) were best fit locally to two-state unfolding model
(solid lines). (B) These two data sets, along with an additional CD unfolding
data set and a FL refolding data set (open boxes and triangles, respectively),
were fit globally to the same model and are shown normalized to the fraction
unfolded. The solid line represents the global fit and the fitted parameters are
given in Table 1. The residuals between the data and the fits are shown in the
panels below. Conditions are described in the legend to Table 1.Biophysical Journal 96(10) 4221–4230either rate constant or amplitude with changing final EPO
concentration.
Due to the relatively long mixing time of between 8 and
10 s, all manual mixing folding data monitored by FL and
CD only fit to a single exponential equation, with rate
constants matching those of the slow SF-FL phase. SF-FL
data were monitored using a 320 nm cutoff filter; however,
manual mixing FL data were detected at different wave-
lengths using a monochrometer. When folding was moni-
tored at 325 nm, the FL signal decreased after mixing to final
urea concentrations between 1 and ~3 M. When folding to
final urea concentrations >3 M, the FL intensity increased
(Fig. 3 C). This interesting phenomenon may be indicative
of a kinetic intermediate and is discussed later.
Unfolding of EPO
Unfolding reactions of EPO were also rather slow and
required approximately between 3 and 10min before reaching
equilibrium when unfolding to final urea concentrations
ranging from 7 to 4.5 M, respectively. Due to these slow
unfolding times, manual mixing was used to jump from 0 M
urea to the various final urea concentrations. The unfolding
kinetic traces monitored by both CD and FL were best
described by a single exponential equation at all final urea
unfolding concentrations between 4.5 and 7.6M. A represen-
tative manual mixing unfolding kinetic trace to 5.8 M urea
monitored by CD is shown in Fig. 3 D demonstrating the
appropriateness of this model and showing that even when
unfolding to strong denaturant concentrations, >95% of the
unfolding reaction was accounted for by manual mixing.
Urea concentration dependence of folding
and unfolding reactions
The urea concentration dependence of the locally fitted
SF-FL and manually mixed CD and FL folding and unfold-
ing rate constants are shown in the chevron plot (Fig. 4 A).
The logarithm of the slow refolding rate constants shows
a linear dependence on the final urea concentration between
2.8 and 4 M urea. Below 2.8 M, the denaturant concentration
dependence of the slow folding phase deviates from linearity
and shows a pronounced curvature or ‘‘roll-over’’. Refolding
data within the linear regions of the intermediate and slow
kinetic folding phases of the chevron plot were fit globally
to Eq. 4 to determine the rates of folding in the absence of
denaturant and the kinetic mz-values. Twenty-four FL and
CD kinetic folding traces collected by manual mixing were
fit between 2.8 and 4 M urea. A total of 29 SF-FL and
manual mixed FL and CD folding traces were fit between
0.6 and 1.6 M urea for the slow folding phase, and 21
SF-FL folding traces were fit between 0.6 and 1.6 M urea
for the intermediate folding phase. The fast kinetic folding
phase (Fig. 4 A, inset) was not fit and is discussed later.
The rate of unfolding in the absence of denaturant and
associated mz-value were determined from the global fit of
Folding Mechanism of Erythropoietin 4225FIGURE 3 Representative stopped-flow and manual
mixed EPO folding and unfolding kinetic traces monitored
by far-UV CD at 222 nm and intrinsic tryptophan FL. (A)
SF-FL data monitored with a 320 nm cutoff filter was best
fit to a sum of three exponential equations. The residuals
of this fit and of a single and double exponential fit are
overlaid for comparison in the panel below as black, dark
gray, and light gray lines, respectively. The inset is a magni-
fication of the initial time points of the folding reaction. (B)
The kinetic amplitudes of SF-FL folding. The solid circles,
squares, and triangles represent folding from the fast, inter-
mediate, and slow phases respectively. (C) Manual mixing
folding monitored by FL at 325 nm was best fit to a single
exponential equation and showed evidence of a hyper-
fluorescent intermediate populated within the time of
mixing. The numbers corresponding to each trace indicate
the final urea concentration EPOwas folded to. (D) Unfold-
ing of EPO to 5.8 M urea by manual mixing monitored by
CD. The solid line represents the local fit of the data to
a single exponential equation with residuals of the fit
shown in the inset. The horizontal line is the folded signal
at the same EPO concentration and an extrapolation of this
signal to the end of the unfolding time. Conditions are
described in the legend to Table 1.22 manually mixed FL and CD kinetic unfolding traces to
Eq. 4 within the linear region of Fig. 4 A, between the final
urea concentrations of 5.2 and 7.4 M.
Burst-phase folding analysis
Burst-phase analysis was used to indirectly reveal the pres-
ence of a possible folding intermediate that cannot be detected
during the dead time of the stopped-flow instrument. As
shown in Fig. 4 B, a small amount of structure appears to
form within the dead time of the SF-FL instrument. Unfortu-
nately stopped-flowmixingwas only possible when refolding
to urea concentrations no higher than ~3 M or within the
folded baseline region of the equilibrium curve. When trying
to refold to higher urea concentrations, the relaxation times
became too long, and the solution within the stopped-flow
flow-cell would become unstable due to diffusion or convec-
tive flow.
DISCUSSION
Analysis of the chevron plot
The presence of the two faster folding phases and the
pronounced roll-over or curvature in the folding limb of
the chevron plot in Fig. 4 A indicate that the folding mecha-
nism of EPO may deviate from simple two-state behavior.
Several possibilities may be responsible for the curvature
of the folding limb of the chevron plot including: heteroge-
neity of the unfolded state, the presence of transient aggrega-
tion, and the population of folding intermediates (21,24).
Heterogeneity of the unfolded state leads to multiple
folding phases or curvature in the folding limb of the chevron
plot when the rate of interconversion of the unfolded species(for example cis-trans isomerization at Xaa-Pro peptide
bonds) is slower or on the same timescale as the folding
reactions leading to the native state, respectively (21). This
possibility can be ruled out; unlike folding through interme-
diate states, the folding amplitudes from multiple unfolded
states only depend on the relative population of each
unfolded species present at the initiation of the folding
reaction, and not on the final urea concentration EPO was
folded to as shown in Fig. 3 B (25). Moreover, folding reac-
tions that are limited by an isomerization events do not
display a strong denaturant dependence on the folding rate
constants or mz-value (26), which is not the case as demon-
strated in Fig. 4 A.
The formation of transient aggregate or an off-pathway
intermediate species upon folding is another possible expla-
nation for multiple kinetic phases and curvature within the
refolding limb of the chevron plot (24). A good indication
that this may be occurring is if the rates of folding increase
with increasing final folding denaturant concentration (a
positive mz-value), signifying that the protein is dissociating
or unfolding before folding to the native state (24). This
appears to be the case for the fast folding phase of EPO
monitored by SF-FL (Fig. 4 A, inset). To test whether this
phase represents the unfolding of aggregate, the protein
concentration dependence of the folding reaction was deter-
mined by folding to EPO concentrations between 1 and
10 mM. When folding at or below 2 mM EPO the fast kinetic
phase disappeared and the folding reaction, even at the
lowest final denaturant concentration, were best fit to the
sum of two exponential equations. The protein concentration
dependence of this phase indicates that it may represent the
unfolding of transient aggregate; alternatively it may be
reporting on the unfolding of an off-pathway intermediateBiophysical Journal 96(10) 4221–4230
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to its low amplitude and the limit of detection of the SF-FL
instrument. Importantly, the rates of the two slower kinetic
phases slow with increasing final urea concentration and
their corresponding amplitudes did not change with protein
concentration, suggesting that the intermediate and slow
phases represent productive folding from monomer.
If the fast folding phase does represent the unfolding reac-
tion of an off-pathway species, as its mz-value suggests, then
some amount of folding takes place within the dead-time of
FIGURE 4 (A) Urea concentration dependence of the folding and unfold-
ing reactions. Local fits of the SF-FL folding data are represented by solid
squares (inset), solid circles, and open triangles. All manual mixing FL
and CD data is shown by open circles and squares, respectively. Error
bars represent the standard deviation of multiple kinetic traces and are
smaller than all of the manual mixing data points. (B) SF-FL burst-phase
analysis. The solid triangles are the FL signals calculated at the time of
mixing from kinetic refolding traces that have been normalized to the folded
baseline region of an equilibrium unfolding curve generated using a 320 nm
cutoff filter (open boxes). This curve was fit to a two-state equilibriummodel
(solid line) to better define the unfolded baseline region (dashed line). Error
bars represent the standard deviations of three refolding experiments and
three equilibrium curves. Conditions are described in the legend to Table 1.Biophysical Journal 96(10) 4221–4230the SF-FL instrument. To test this hypothesis burst-phase
analysis was used to indirectly monitor the formation of
structure between the time of stopped-flow mixing and the
first observable FL signal. Unfortunately, it was not possible
to produce a complete equilibrium unfolding curve using the
final SF-FL signals from the folding and unfolding reactions
due to the long collection times within the folding/unfolding
transition region, which were beyond the capabilities of the
instrumentation. The SF-FL data were therefore normalized
to an equilibrium curve generated using the same 320 nm
cutoff filter used for the stopped-flow detection. This resulted
in a relatively shallow unfolding curve with a poorly defined
unfolded baseline with a large positive slope (Fig. 4 B). The
unfolding curve was therefore fit to the two-state unfolding
model, fixing the equilibrium parameters to those previously
determined, to better define the unfolded baseline. The
extrapolation of this baseline revealed a small difference
between it and the FL signal calculated at the time of mixing,
indicating the presence of an intermediate or collapsed state
with a lower FL quantum yield than the unfolded state popu-
lated during the dead time of the instrument. We speculate
that the fast folding phase represents the unfolding of this
relatively unstable burst-phase species formed within the
5 ms dead time of the SF-FL instrument. This interpretation
must be viewed with some caution, however, due to the diffi-
culty in accurately defining the slope of the unfolded base-
line.
Based on the previous arguments, the best explanation
for the curvature of the folding limb of the chevron plot
and the observed intermediate kinetic folding phase by
SF-FL is the formation of a transient intermediate species
during the folding of EPO. The manual mixing times
required for refolding experiments were too long to observe
this intermediate kinetic phase directly; therefore we are
unable to comment on the formation of secondary structure
of the intermediate species. Manual mixing folding experi-
ments monitored by FL at 325 nm also revealed an inter-
esting phenomenon not seen by SF-FL that used a 320 nm
cutoff filter. When EPO was folded to low denaturant
concentrations, the FL intensity decreased as the protein
folded. However, when folding to urea concentrations above
~2.9 M and greater, the FL intensity increased as the protein
folded (Fig. 3 C). This phenomenon is not due to the urea
dependence on the native and unfolded state FL signals at
325 nm as demonstrated by the equilibrium unfolding curve
in Fig. 2 A collected at this wavelength. These observations
suggest that an intermediate with a greater FL quantum yield
at 325 nm than either the unfolded state in 6 M urea or the
folded state is formed within the time required for manual
mixing. At a concentration of ~2.9 M urea, this intermediate
is destabilized and folding proceeds directly from the
unfolded state. Unfortunately these data alone give no indi-
cation of whether the intermediate is either on or off-pathway
because there would be a net decrease in the FL signal at this
wavelength for either mechanism.
Folding Mechanism of Erythropoietin 4227The cause for the increased FL of the intermediate species
is likely due to tryptophan 88. In the native state, this trypto-
phan is adjacent to the disulfide bond connecting cysteines
29 and 33 and has been reported to be largely quenched
(27) (Fig. 1). In the unfolded state, this should no longer
be the case, and all three tryptophan residues would be
more or less equally quenched by solvent relative to the
folded state (at 325 nm). We speculate that upon folding,
Trp-88 is partially buried in the structure of the intermediate
species, away from the disulfide connecting cysteines 29 and
33, thereby increasing its quantum yield. As the protein folds
to the native species, Trp-88 would move into range of the
disulfide and the total FL intensity would be expected to
decrease.
Determination of the three-state folding model
There are three possible folding mechanisms with a single
intermediate species that may account for the intermediate
and slow observable rate constants. They are the sequential,
off-pathway and parallel folding schemes (Fig. 5 A).
Discrimination between these three mechanisms is not
possible using the folding kinetics of EPO alone (21). The
analytical solutions of the differential equations describing
each of these three mechanisms were therefore used to distin-
guish which mechanism best described the observed urea
concentration dependence of the folding and unfolding rates.
The logarithm of each of the folding and unfolding rate
constants were assumed to change linearly with urea concen-
tration (28). The results of the global fits within the linear
regions of the chevron plot to Eq. 4 were therefore used as
the initial parameters (the microscopic rate constants) for
determining which of the three possible kinetic schemes
(Fig. 5 A) best described the urea concentration dependence
of the two observed rate constants. These parameters were
well constrained by the observed rates due to the stability
of the intermediate species. The only parameters not defined
by the observed kinetic rates were the microscopic rate
constant and associated mz-value for the unfolding of the
intermediate species. However, these values were also well
constrained because they define, together with kUI and
mzUI, the extent of curvature observed for the slower folding
rate constant dependence on final urea concentration. The
exact parameters determined from the global fits of the
observed data (Table 1) were used first in the on-pathway
model, Eq. 5, to calculate kIU and m
z
IU and were able to
adequately reproduce the urea concentration dependence of
the two observed rate constants (Fig. 5 B, red lines). In
contrast, the urea concentration dependence of the observed
kinetic rates could not be reproduced using either the off-
pathway or parallel folding models no matter how the micro-
scopic rate constants were varied (Fig. 6).
The kinetic parameters derived from the best fits to each of
the three three-state models were used to calculate the ampli-
tudes of the observed folding reactions and simulate thefolding traces. Only the microscopic rate constants from
the on-pathway model were able to simulate the folding
kinetics using realistic values for the FL intensities of the
unfolded and intermediate species. For example, the on-
pathway microscopic rate constants simulated the folding
trace shown in Fig. 3 A using FL intensity values for the
unfolded and intermediate species of 2.1 and 1.83, respec-
tively. The parameters from the off and parallel pathway
models could only simulated the folding trace in Fig. 3 A
using illogical FL intensity values for the unfolded and inter-
mediate species such as 4.9 and 0.63 for the off-pathway
model and 1.89 and 1.78 for the parallel pathway model.
Further support for the validity of the on-pathway three-state
folding mechanism was the excellent agreement between the
free energy and m-values for the equilibrium unfolding of
EPO calculated from the kinetic data assuming the on-
pathway mechanism (7.2  0.2 kcal mol1 and 1.65 
0.07 kcal mol1 M1), and these values determined directly
FIGURE 5 (A) Three possible three-state folding mechanisms that
describe a two exponential process. The intermediate (I) may be either
on-pathway, off-pathway, or folding may proceed directly to the native state
(N) from the unfolded ensemble (U), as well as through an intermediate in
a parallel pathway mechanism. The microscopic rate constants are shown
above and below the arrows. (B) Urea concentration dependence of the
folding and unfolding reactions fit to a three-state on-pathway model. The
microscopic rate constants (solid black lines) were calculated using Eq. 4
and used as initial parameters for fitting the two observed rate constants
(red dashed and solid lines) using the on-pathway mechanism, Eq. 5. All
data points are the same as those described in Fig. 4 A. Fitted values of
the rate constants and mz-values are given in Table 1. Conditions are
described in the legend to Table 1.Biophysical Journal 96(10) 4221–4230
4228 Banks et al.from the equilibrium unfolding experiments (7.2  0.1 kcal
mol1 and 1.69  0.03 kcal mol1 M1). Whether or not
a small fraction of EPO may fold directly to the native state
is difficult to rule out at this time, however, given the ability
of the on-pathway model to reproduce the urea concentration
dependence of the observed folding rates, folding ampli-
tudes, and calculate the equilibrium unfolding parameters,
we believe the folding mechanism of EPO to be predomi-
nately on-pathway.
The free energy proﬁle of EPO folding
The observed and microscopic rate constants for the on-
pathway three-state folding mechanism (Table 1) were
used to calculate the change in free energy during the course
of EPO folding/unfolding at three different urea concentra-
tions using Eq. 6 (Fig. 7). The stability of the transition states
between each of these kinetic species were estimated by tran-
FIGURE 6 Urea dependence of the two observable rate constants fit to an
off-pathway model (A) and to a parallel or triangle mechanism (B). Fits of
the two observable rate constants are shown as red dashed and solid lines.
All data points are the same as those described in Fig. 4 A.Biophysical Journal 96(10) 4221–4230sition state theory using a preexponential factor that takes
into consideration intrachain diffusion processes, Eq. 7
(23). The progress of the folding reaction is plotted as a func-
tion of b. The values of b for each species were calculated
using Eq. 8 and the kinetically derived mz-values and depicts
the relative compactness of each of the kinetic species (8).
The values of b vary from 0 to 1 for kinetic species resem-
bling the unfolded and native species in their degree of
compaction or burial of surface area, respectively.
Based on the kinetic and equilibrium data, we propose that
EPO folds initially to an off-pathway intermediate species
(which may be aggregate) of limited stability within the 5 ms
dead time of the stopped-flow instrument. This species
unfolds within the first 300 ms of the observable reaction,
and the folding of EPO proceeds predominately to an inter-
mediate ensemble through a loosely packed transition state,
which occludes only 18% of the total surface area buried
in the native state. The intermediate state buries ~70% of
the total surface area buried in the native state. Based on
the manual mixing refolding data monitored by FL emission
at 325 nm, we speculate that the compaction of the remaining
30% of surface area from the intermediate to native state
involves a reconfiguration of the BC and AB loops contain-
ing tryptophan 88 and the disulfide bond connecting cyste-
ines 29 and 33, respectively.
Comparison to the folding of G-CSF
Statistically significant correlations have been found between
protein folding rates and mechanisms of relatively small
single domain proteins to both protein stability and topolog-
ical complexity, measured by a number of parameters such
as contact order and the number of sequence-distant native
FIGURE 7 Free energy diagram of EPO folding and unfolding at 0 M,
3 M, and 6 M urea concentrations. Energy levels were calculated using
the parameters in Table 1 and Eqs. 6 and 7. The reaction coordinate
describes the amount of burial of surface area relative to the native state
or bT value calculated using Eq. 8.
Folding Mechanism of Erythropoietin 4229pairs (10,29). Proteins with more local contacts in the native
structure were shown to fold at faster rates (10,29). We there-
fore thought it would be informative to compare the folding
mechanism of EPO to other members of the four-helical
bundle cytokine family that share a high degree of structural
similarity to EPO and have been previously studied by kinetic
folding methods. Comparisons to the folding mechanisms of
the bovine and human growth hormones were difficult to
make due to aggregation and precipitation observed when
the E. coli derived growth hormones were refolded to the
low denaturant concentrations where the intermediate folding
phase of EPO was observed (11,12). This observation was
likely due to the lack of glycosylation of the growth
hormones, which has been noted to increase protein stability
and solubility and minimize aggregation upon refolding
(30,31). These observations were also made when EPO was
expressed in E. coli; the nonglycosylated EPO was 1.4 kcal
mol1 less stable than CHO expressed EPO and was prone
to aggregation and precipitation (3).
Aggregationwhen folding to lowdenaturant concentrations
was not as problematic for the E. coli expressed nonglycosy-
lated G-CSF. The denaturant dependence of the folding and
unfolding rates are comparable to those observed for EPO,
and a similar sequential folding mechanism with a populated
intermediate was recently proposed (13). Interestingly, the
folding rate constants were ~2 orders of magnitude faster
than observed for EPO despite the studies being conducted
at 10C. It is therefore somewhat surprising that EPO and
G-CSF, which share the same fold (the four-helical bundle
of EPOsuperimposes onG-CSFwith a rootmean-square devi-
ation of only 1.6 A˚ (4)) and similar stabilities, should have
such a large discrepancy in their folding and unfolding rates.
The effect of glycosylation on the detailed kinetic folding
mechanisms of proteins is not well understood (14,15).
Studies of small synthesized glycopeptides have led to the
hypothesis that glycosylation of proteins may influence their
rates of folding by limiting or restricting conformational
space, thereby biasing particular folding pathways and
speeding up the folding process (15). It may also be argued
that such conformational restrictions or rigidity may increase
the height of transition state energy barriers for steric reasons
and slow the folding or unfolding processes as proposed for
horseradish peroxidase (32). Which scenario is more likely
may be protein specific, depending on the location of glyco-
sylation and these regions involvement in the rate limiting
step of folding. The folding mechanism of EPO and G-CSF
appear to be conserved; however, their folding and unfolding
rates are dissimilar.We speculate that the relatively slow EPO
kinetics may be due to the significant amount of glycosylation
on four residues compared to the nonglycosylated G-CSF,
although other factors may contribute to these slower rates
such as differences in the disulfide bond connectivity. This
large amount of carbohydrate may not change the folding
pathway of EPO, but could be enough to increase the ener-
getic roughness of the folding landscape and slow downthe folding and unfolding reactions while minimizing the
potential for off-pathway aggregation events of folding inter-
mediate(s).
The authors thank Lisa M. Gloss, Michael Treuheit, and David Brems for
critical review, helpful comments, and discussions.
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